Predictive analytics identifies key factors driving hyperalgesic priming of muscle sensory neurons.

Front Neurosci

Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, US Army Medical Research and Development Command, Fort Detrick, MD, United States.

Published: October 2023

Hyperalgesic priming, a form of neuroplasticity induced by inflammatory mediators, in peripheral nociceptors enhances the magnitude and duration of action potential (AP) firing to future inflammatory events and can potentially lead to pain chronification. The mechanisms underlying the development of hyperalgesic priming are not well understood, limiting the identification of novel therapeutic strategies to combat chronic pain. In this study, we used a computational model to identify key proteins whose modifications caused priming of muscle nociceptors and made them hyperexcitable to a subsequent inflammatory event. First, we extended a previously validated model of mouse muscle nociceptor sensitization to incorporate Epac-mediated interaction between two G protein-coupled receptor signaling pathways commonly activated by inflammatory mediators. Next, we calibrated and validated the model simulations of the nociceptor's AP response to both innocuous and noxious levels of mechanical force after two subsequent inflammatory events using literature data. Then, by performing global sensitivity analyses that simulated thousands of nociceptor-priming scenarios, we identified five ion channels and two molecular processes (from the 18 modeled transmembrane proteins and 29 intracellular signaling components) as potential regulators of the increase in AP firing in response to mechanical forces. Finally, when we simulated specific neuroplastic modifications in Kv1.1 and Nav1.7 alone as well as with simultaneous modifications in Nav1.7, Nav1.8, TRPA1, and Kv7.2, we observed a considerable increase in the fold change in the number of triggered APs in primed nociceptors. These results suggest that altering the expression of Kv1.1 and Nav1.7 might regulate the neuronal hyperexcitability in primed mechanosensitive muscle nociceptors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629345PMC
http://dx.doi.org/10.3389/fnins.2023.1254154DOI Listing

Publication Analysis

Top Keywords

hyperalgesic priming
12
priming muscle
8
inflammatory mediators
8
inflammatory events
8
muscle nociceptors
8
subsequent inflammatory
8
validated model
8
kv11 nav17
8
inflammatory
5
predictive analytics
4

Similar Publications

Article Synopsis
  • Postoperative hyperalgesic priming, made worse by preoperative anxiety, complicates pain management after surgery, and electroacupuncture (EA) may help by targeting multiple biological pathways.
  • This review explores how EA can tackle issues related to preoperative anxiety and postoperative pain chronification by investigating its effects on the body's response systems.
  • EA has shown effectiveness in reducing preoperative anxiety and postoperative pain through mechanisms like reducing inflammation, modulating pain pathways, and improving stress hormone regulation, suggesting it could enhance patient recovery after surgery.
View Article and Find Full Text PDF

Nociceptors with somata in dorsal root ganglia (DRGs) readily switch from an electrically silent state to a hyperactive state of tonic, nonaccommodating, low-frequency, irregular discharge of action potentials (APs). Spontaneous activity (SA) during this state is present in vivo in rats months after spinal cord injury (SCI) and has been causally linked to SCI pain. Intrinsically generated SA and, more generally, ongoing activity (OA) are induced by various neuropathic conditions in rats, mice, and humans and are retained in nociceptor somata after dissociation and culturing, providing a powerful tool for investigating its mechanisms and functions.

View Article and Find Full Text PDF

Persistent hyperactivity of nociceptors is known to contribute significantly to long-lasting sensitization and ongoing pain in many clinical conditions. It is often assumed that nociceptor hyperactivity is mainly driven by continuing stimulation from inflammatory mediators. We have tested an additional possibility: that persistent increases in excitability promoting hyperactivity can be induced by a prototypical cellular signaling pathway long known to induce late-phase long-term potentiation (LTP) of synapses in brain regions involved in memory formation.

View Article and Find Full Text PDF

Chronic pain remains a significant health challenge with limited effective treatments. This study investigates the metabolic changes underlying pain progression and resolution, uncovering a novel compensatory mechanism in sensory neurons. Using the hyperalgesic priming model in male mice, we demonstrate that nerve growth factor (NGF) initially disrupted mitochondrial pyruvate oxidation, leading to acute allodynia.

View Article and Find Full Text PDF

Mu-Opioid Receptor (MOR) Dependence of Pain in Chemotherapy-Induced Peripheral Neuropathy.

J Neurosci

October 2024

Department of Oral and Maxillofacial Surgery, UCSF Pain and Addiction Research Center, University of California at San Francisco, San Francisco, California 94143

Article Synopsis
  • * Our research on male rats showed that blocking mu-opioid receptors (MOR) decreases pain and the increased sensitivity (priming) associated with common chemotherapy drugs like oxaliplatin and paclitaxel.
  • * Additionally, we discovered that while normal morphine doesn't cause pain sensitivity in healthy rats, it worsens pain in those with chemotherapy-induced nerve damage, highlighting the challenges of opioids for treating this type of neuropathic pain.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!